« Previous Next » The American Journal of Medicine
Volume 120, Issue 7 , Pages 616-622 , July 2007

C-Reactive Protein and Heart Failure after Myocardial Infarction in the Community

Francesca Bursi, MD, MSc
- Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn
Susan A. Weston, MS
- Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn.
Jill M. Killian, BS
- Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn.
Sherine E. Gabriel, MD, MSc
- Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn.
Steven J. Jacobsen, MD, PhD
- Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn.
Véronique L. Roger, MD, MPH
- Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn
- Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn.
- Requests for reprints should be addressed to Véronique L. Roger, MD, MPH, Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55901.

Survival free of heart failure (top) and overall survival (bottom) according to CRP tertiles. Hs-CRP = high sensitivity C-reactive protein.

Survival free of heart failure (top) and overall survival (bottom) according to CRP tertiles. Hs-CRP = high sensitivity C-reactive protein.
- Full-Size Image
- Download to PowerPoint

Supported in part by grants from the Public Health Service and the National Institutes of Health (AR30582, R01 HL 59205, R01 HL 72435) and by an American Heart Association Postdoctoral Greater Midwest Fellowship Award to Dr Bursi. Dr Roger is an Established Investigator of the American Heart Association.

PII: S0002-9343(06)01064-3

doi: 10.1016/j.amjmed.2006.07.039

« Previous Next » The American Journal of Medicine
Volume 120, Issue 7 , Pages 616-622 , July 2007